A widely used diabetes drug has come under new scrutiny after two large studies found it may be linked to a rare but serious eye condition that can cause permanent vision loss.
The medication, known as Ozempic, is commonly prescribed to people with type 2 diabetes to help control blood sugar levels and support weight loss.
Type 2 diabetes is a long-term condition that affects how the body processes sugar. When the body cannot use insulin properly, sugar builds up in the blood. Over time, this can damage many organs, including the eyes. Because of this, people with diabetes are already at higher risk of eye problems, making any new risks especially important to understand.
The new research comes from the University of Southern Denmark and is based on large sets of health data collected in Denmark and Norway. The findings were shared on the research platform medRxiv.
Together, the two studies looked at hundreds of thousands of people with type 2 diabetes to better understand whether Ozempic could be linked to a condition called non-arteritic anterior ischemic optic neuropathy, or NAION.
NAION is a rare eye disease that happens when blood flow to the optic nerve is reduced. The optic nerve carries visual information from the eye to the brain. If it is damaged, it can lead to sudden vision loss that is often permanent. There is currently no effective treatment to reverse this damage, which makes prevention very important.
The first study was led by Professor Jakob Grauslund. It examined health records from more than 424,000 adults with type 2 diabetes. Among them, over 100,000 people were using Ozempic. The researchers found that people taking Ozempic were about twice as likely to develop NAION compared to those using other diabetes medications.
The study also found that the number of NAION cases in Denmark has increased since Ozempic became widely available in 2018. Before the drug was introduced, there were around 60 to 70 cases each year.
In recent years, that number has risen to as many as 150 cases per year. This increase has raised concerns about a possible connection between the medication and optic nerve damage.
The second study, led by Professor Anton Pottegård, used a different approach to confirm the findings. It compared new users of Ozempic with patients who were taking other diabetes drugs at a similar stage of their illness.
This study included data from both Denmark and Norway, which helped strengthen the results. It also found that Ozempic users had about double the risk of developing NAION.
Importantly, the increased risk was seen across all patients with type 2 diabetes, not only those with more severe disease. This suggests that the potential risk is not limited to a specific subgroup.
Despite these findings, experts are not advising patients to stop taking Ozempic without medical guidance. The condition remains very rare, and the overall risk for most people is still low.
Ozempic has clear benefits, including helping to lower blood sugar and support weight loss. These effects can reduce the risk of serious complications such as heart disease and kidney problems.
Doctors stress that treatment decisions should always be based on a careful balance of risks and benefits. For many patients, the advantages of using Ozempic may still outweigh the potential risks. However, patients should be aware of possible warning signs, such as sudden changes in vision, and seek medical help if they notice anything unusual.
If a patient develops NAION in one eye, doctors generally recommend stopping the medication right away to reduce the chance of further damage.
Health authorities in Denmark and other countries have been informed about these findings and are now reviewing the data. The results may influence future treatment guidelines for diabetes, especially if more studies confirm the link.
Researchers are also working to understand why this drug might affect the optic nerve. It is not yet clear what causes the increased risk or which patients may be more vulnerable. More research is needed to answer these questions.
For now, people with type 2 diabetes who are using Ozempic should stay informed and discuss any concerns with their healthcare providers. Regular eye checks and good overall diabetes management remain important steps in protecting vision.
This research highlights an important point in modern medicine. Even well-known and widely used drugs can have unexpected side effects. Careful monitoring and ongoing research are essential to ensure that treatments remain both effective and safe.
If you care about diabetes, please read studies about diabetes and vitamin B12, and the right diet for people with type 2 diabetes.
For more health information, please see recent studies about how to eat smart with diabetes, and turmeric and vitamin D: a duo for blood pressure control in diabetic patients.
Copyright © 2026 Knowridge Science Report. All rights reserved.
